These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 28272457)

  • 1. Novel vaccine potential of Rv3131, a DosR regulon-encoded putative nitroreductase, against hyper-virulent Mycobacterium tuberculosis strain K.
    Kwon KW; Kim WS; Kim H; Han SJ; Hahn MY; Lee JS; Nam KT; Cho SN; Shin SJ
    Sci Rep; 2017 Mar; 7():44151. PubMed ID: 28272457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of immunogenicity and vaccine efficacy between heat-shock proteins, HSP70 and GrpE, in the DnaK operon of Mycobacterium tuberculosis.
    Kim WS; Kim JS; Kim HM; Kwon KW; Eum SY; Shin SJ
    Sci Rep; 2018 Sep; 8(1):14411. PubMed ID: 30258084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary immunity and durable protection induced by the ID93/GLA-SE vaccine candidate against the hyper-virulent Korean Beijing Mycobacterium tuberculosis strain K.
    Cha SB; Kim WS; Kim JS; Kim H; Kwon KW; Han SJ; Cho SN; Coler RN; Reed SG; Shin SJ
    Vaccine; 2016 Apr; 34(19):2179-87. PubMed ID: 27005808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenic potential of latency associated antigens against Mycobacterium tuberculosis.
    Singh S; Saraav I; Sharma S
    Vaccine; 2014 Feb; 32(6):712-6. PubMed ID: 24300592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccine efficacy of a
    Kwon KW; Choi HH; Han SJ; Kim JS; Kim WS; Kim H; Kim LH; Kang SM; Park J; Shin SJ
    FASEB J; 2019 May; 33(5):6483-6496. PubMed ID: 30753099
    [No Abstract]   [Full Text] [Related]  

  • 6. Protective Vaccine Efficacy of the Complete Form of PPE39 Protein from Mycobacterium tuberculosis Beijing/K Strain in Mice.
    Kim A; Hur YG; Gu S; Cho SN
    Clin Vaccine Immunol; 2017 Nov; 24(11):. PubMed ID: 28877927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A putative nitroreductase from the DosR regulon of Mycobacterium tuberculosis induces pro-inflammatory cytokine expression via TLR2 signaling pathway.
    Peddireddy V; Doddam SN; Qureshi IA; Yerra P; Ahmed N
    Sci Rep; 2016 Apr; 6():24535. PubMed ID: 27094446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double- and monofunctional CD4⁺ and CD8⁺ T-cell responses to Mycobacterium tuberculosis DosR antigens and peptides in long-term latently infected individuals.
    Commandeur S; Lin MY; van Meijgaarden KE; Friggen AH; Franken KL; Drijfhout JW; Korsvold GE; Oftung F; Geluk A; Ottenhoff TH
    Eur J Immunol; 2011 Oct; 41(10):2925-36. PubMed ID: 21728172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term protective efficacy with a BCG-prime ID93/GLA-SE boost regimen against the hyper-virulent Mycobacterium tuberculosis strain K in a mouse model.
    Kwon KW; Lee A; Larsen SE; Baldwin SL; Coler RN; Reed SG; Cho SN; Ha SJ; Shin SJ
    Sci Rep; 2019 Oct; 9(1):15560. PubMed ID: 31664157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DosR proteins of Mycobacterium tuberculosis upregulate effector T cells and down regulate T regulatory cells in TB patients and their healthy contacts.
    Pandey K; Singh S; Bhatt P; Medha ; Sharma M; Chaudhry A; Sharma S
    Microb Pathog; 2019 Jan; 126():399-406. PubMed ID: 30476579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of human T cell antigens for the development of vaccines against Mycobacterium tuberculosis.
    Bertholet S; Ireton GC; Kahn M; Guderian J; Mohamath R; Stride N; Laughlin EM; Baldwin SL; Vedvick TS; Coler RN; Reed SG
    J Immunol; 2008 Dec; 181(11):7948-57. PubMed ID: 19017986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mycobacterium tuberculosis Rv3628 drives Th1-type T cell immunity via TLR2-mediated activation of dendritic cells and displays vaccine potential against the hyper-virulent Beijing K strain.
    Kim WS; Kim JS; Cha SB; Kim H; Kwon KW; Kim SJ; Han SJ; Choi SY; Cho SN; Park JH; Shin SJ
    Oncotarget; 2016 May; 7(18):24962-82. PubMed ID: 27097115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity and Vaccine Potential of InsB, an ESAT-6-Like Antigen Identified in the Highly Virulent
    Kim WS; Kim H; Kwon KW; Cho SN; Shin SJ
    Front Microbiol; 2019; 10():220. PubMed ID: 30809214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The in vivo expressed Mycobacterium tuberculosis (IVE-TB) antigen Rv2034 induces CD4⁺ T-cells that protect against pulmonary infection in HLA-DR transgenic mice and guinea pigs.
    Commandeur S; van den Eeden SJ; Dijkman K; Clark SO; van Meijgaarden KE; Wilson L; Franken KL; Williams A; Christensen D; Ottenhoff TH; Geluk A
    Vaccine; 2014 Jun; 32(29):3580-8. PubMed ID: 24837764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection against Mycobacterium tuberculosis infection offered by a new multistage subunit vaccine correlates with increased number of IFN-γ+ IL-2+ CD4+ and IFN-γ+ CD8+ T cells.
    Wang X; Zhang J; Liang J; Zhang Y; Teng X; Yuan X; Fan X
    PLoS One; 2015; 10(3):e0122560. PubMed ID: 25822536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucosal delivery of antigen-coated nanoparticles to lungs confers protective immunity against tuberculosis infection in mice.
    Stylianou E; Diogo GR; Pepponi I; van Dolleweerd C; Arias MA; Locht C; Rider CC; Sibley L; Cutting SM; Loxley A; Ma JK; Reljic R
    Eur J Immunol; 2014 Feb; 44(2):440-9. PubMed ID: 24214530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multistage-polyepitope vaccine protects against Mycobacterium tuberculosis infection in HLA-DR3 transgenic mice.
    Geluk A; van den Eeden SJ; van Meijgaarden KE; Dijkman K; Franken KL; Ottenhoff TH
    Vaccine; 2012 Dec; 30(52):7513-21. PubMed ID: 23103299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific immune responses induced by multi-epitope DNA derived from Mycobacterium tuberculosis DosR antigens.
    Moradi J; Izad M; Tabrizi M; Mosavari N; Esmaeili B; Feizabadi MM
    Acta Microbiol Immunol Hung; 2018 Jun; 65(2):193-209. PubMed ID: 29552899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic efficacy of a tuberculosis DNA vaccine encoding heat shock protein 65 of Mycobacterium tuberculosis and the human interleukin 2 fusion gene.
    Changhong S; Hai Z; Limei W; Jiaze A; Li X; Tingfen Z; Zhikai X; Yong Z
    Tuberculosis (Edinb); 2009 Jan; 89(1):54-61. PubMed ID: 19056317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the DosR regulon genes to select cytotoxic T lymphocyte epitope specific vaccine candidates using a reverse vaccinology approach.
    Pandey K; Sharma M; Saarav I; Singh S; Dutta P; Bhardwaj A; Sharma S
    Int J Mycobacteriol; 2016 Mar; 5(1):34-43. PubMed ID: 26927988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.